4.4 Article

Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging

Journal

METABOLOMICS
Volume 15, Issue 5, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11306-019-1531-4

Keywords

Alkaptonuria; Neurotransmitter; Imaging; Mass spectrometry; Dopamine; Serotonin; Tyrosine; Tyramine; Tryptophan

Funding

  1. National Institute for Health Research (NIHR) Doctoral Research Fellowship [HCS DRF-2014-05-009]
  2. NIHR
  3. National Institutes of Health Research (NIHR) [HCS DRF-2014-05-009] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

ObjectiveNitisinone induced hypertyrosinaemia is a concern in patients with Alkaptonuria (AKU). It has been suggested that this may alter neurotransmitter metabolism, specifically dopamine and serotonin. Herein mass spectrometry imaging (MSI) is used for the direct measurement of 2,4-diphenyl-pyranylium tetrafluoroborate (DPP-TFB) derivatives of monoamine neurotransmitters in brain tissue from a murine model of AKU following treatment with nitisinone.MethodsMetabolite changes were assessed using MSI on DPP-TFB derivatised fresh frozen tissue sections directing analysis towards primary amine neurotransmitters. Matched tail bleed plasma samples were analysed using LC-MS/MS. Eighteen BALB/c mice were included in this study: HGD(-/-) (n=6, treated with nitisinone4mg/L, in drinking water); HGD(-/-) (n=6, no treatment) and HGD(+/-) (n=6, no treatment).ResultsIon intensity and distribution of DPP-TFB derivatives in brain tissue for dopamine, 3-methoxytyramine, noradrenaline, tryptophan, serotonin, and glutamate were not significantly different following treatment with nitisinone in HGD (-/-) mice, and no significant differences were observed between HGD(-/-) and HGD(+/-) mice that received no treatment. Tyrosine (10-fold in both comparisons, p=0.003; [BALB/c HGD(-/-) (n=6) and BALB/c HGD(+/-) (n=6) (no treatment) vs. BALB/c HGD(-/-) (n=6, treated)] and tyramine (25-fold, p=0.02; 32-fold, p=0.02) increased significantly following treatment with nitisinone. Plasma tyrosine and homogentisic acid increased (ninefold, p=< 0.0001) and decreased (ninefold, p=0.004), respectively in HGD(-/-) mice treated with nitisinone.ConclusionsMonoamine neurotransmitters in brain tissue from a murine model of AKU did not change following treatment with nitisinone. These findings have significant implications for patients with AKU as they suggest monoamine neurotransmitters are not altered following treatment with nitisinone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available